Ahead of Reuters Pharma 2022, Antonio Iervolino, Partner out of our Putnam London office describes 5 major shifts that pharma companies will have to embrace as they design the path to market for their novel assets and provides an analysis on pharma product launches since 2018, identifying trends and measuring their performance against pre-launch expectations.
Antonio distills the key drivers that are critical in developing a virtuous value creating system and designing impactful go-to-market strategies for tomorrow’s healthcare ecosystems.
Read more on the thoughtful analysis and hear from Antonio at Pharma 2022 next week.
Jump to a slide with the slide dots.
ClarityNav reveals rising momentum for Lp(a) at ACC 2025, merging scientific data with digital insights to guide strategy.
Read moreInsights from the 13th CMO Summit: Expanding CMO roles, early Medical Affairs integration, and innovation in clinical trials.
Read moreExplore key themes from MAPS Americas 2025—advancing health equity, AI, and collaboration in Medical Affairs.
Read more